Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth

Glycogen debranching enzyme (AGL) and Glycogen phosphorylase (PYG) are responsible for glycogen breakdown. We have earlier shown that AGL is a regulator of bladder tumor growth. Here we investigate the role of AGL in non-small cell lung cancers (NSCLC). Short hairpin RNA (shRNA) driven knockdown of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Richmond, Craig S., Oldenburg, Darby, Dancik, Garrett, Meier, David R., Weinhaus, Benjamin, Theodorescu, Dan, Guin, Sunny
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908281/
https://ncbi.nlm.nih.gov/pubmed/29682180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24676
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires